EP2893930 - COMPOUNDS FOR ENHANCING ERYTHROPOIESIS [Right-click to bookmark this link] | |||
Former [2015/29] | Compounds for enhancing erythropoiesis | ||
[2019/31] | Status | No opposition filed within time limit Status updated on 12.02.2021 Database last updated on 22.08.2024 | |
Former | The patent has been granted Status updated on 06.03.2020 | ||
Former | Grant of patent is intended Status updated on 02.07.2019 | ||
Former | Examination is in progress Status updated on 06.10.2017 | Most recent event Tooltip | 15.07.2022 | Lapse of the patent in a contracting state New state(s): BE | published on 17.08.2022 [2022/33] | Applicant(s) | For all designated states Wu, Sophia Shu Fen 426 Park Avenue Yonkers, NY 10703 / US | For all designated states Wu, Rong-Tsun No. 155, Sec. 2 Linong Street Taipei 112 / TW | [2015/29] | Inventor(s) | 01 /
Wu, Rong-Tsun No. 155, Sec. 2 Linong Street 112 Taipei / TW | [2015/29] | Representative(s) | Straus, Alexander, et al 2K Patent- und Rechtsanwälte Bajuwarenring 14 82041 Oberhaching / DE | [N/P] |
Former [2020/15] | Straus, Alexander, et al 2K Patent- und Rechtsanwälte Dr. Alexander Straus Keltenring 9 82041 München / Oberhaching / DE | ||
Former [2015/29] | Straus, Alexander Patentanwälte Becker, Kurig, Straus Bavariastrasse 7 80336 München / DE | Application number, filing date | 14176172.6 | 21.12.2009 | [2015/29] | Priority number, date | US20080343922 | 24.12.2008 Original published format: US 343922 | [2015/29] | Previously filed application, date | WO2009US68957 | 21.12.2009 | [2015/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2893930 | Date: | 15.07.2015 | Language: | EN | [2015/29] | Type: | A3 Search report | No.: | EP2893930 | Date: | 12.08.2015 | [2015/33] | Type: | B1 Patent specification | No.: | EP2893930 | Date: | 08.04.2020 | Language: | EN | [2020/15] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.07.2015 | Classification | IPC: | A61K31/7034, A61P7/06, A61P13/12, A61P25/00, A61P9/00, A61P9/10, A61P1/16, A61P11/00, A61P1/00, A61P19/08, A61P19/02, A61P21/00, A61P17/00, A61P43/00, A61P37/08, C07H15/203 | [2019/29] | CPC: |
A61K31/7034 (EP,KR,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/14 (EP);
C07H15/203 (EP,US)
(-)
|
Former IPC [2015/33] | A61K31/7034, A61P7/06, A61P13/12, A61P25/00, A61P9/00, A61P9/10, A61P1/16, A61P11/00, A61P1/00, A61P19/08, A61P19/02, A61P21/00, A61P17/00, A61P43/00, A61P37/08 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2016/12] |
Former [2015/29] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | VERBINDUNGEN ZUR VERSTÄRKUNG DER ERYTHROPOESE | [2019/31] | English: | COMPOUNDS FOR ENHANCING ERYTHROPOIESIS | [2019/31] | French: | COMPOSÉS POUR L'AMPLIFICATION DE L'ÉRYTHROPOÏÈSE | [2019/31] |
Former [2015/29] | Verbindungen zur Verstärkung der Erythropoese | ||
Former [2015/29] | Compounds for enhancing erythropoiesis | ||
Former [2015/29] | Composés pour l'amplification de l'érythropoïèse | Examination procedure | 12.02.2016 | Amendment by applicant (claims and/or description) | 12.02.2016 | Examination requested [2016/12] | 06.10.2017 | Despatch of a communication from the examining division (Time limit: M06) | 04.04.2018 | Reply to a communication from the examining division | 31.08.2018 | Despatch of a communication from the examining division (Time limit: M06) | 27.02.2019 | Reply to a communication from the examining division | 03.07.2019 | Communication of intention to grant the patent | 31.10.2019 | Fee for grant paid | 31.10.2019 | Fee for publishing/printing paid | 31.10.2019 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09775516.9 / EP2381948 | Divisional application(s) | EP19206081.2 / EP3628321 | Opposition(s) | 12.01.2021 | No opposition filed within time limit [2021/11] | Fees paid | Renewal fee | 08.07.2014 | Renewal fee patent year 03 | 08.07.2014 | Renewal fee patent year 04 | 08.07.2014 | Renewal fee patent year 05 | 30.09.2014 | Renewal fee patent year 06 | 18.12.2015 | Renewal fee patent year 07 | 29.12.2016 | Renewal fee patent year 08 | 12.12.2017 | Renewal fee patent year 09 | 12.12.2018 | Renewal fee patent year 10 | 27.02.2020 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 31.12.2019 | 11   M06   Fee paid on   27.02.2020 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 21.12.2009 | AT | 08.04.2020 | CY | 08.04.2020 | CZ | 08.04.2020 | DK | 08.04.2020 | EE | 08.04.2020 | ES | 08.04.2020 | FI | 08.04.2020 | HR | 08.04.2020 | IT | 08.04.2020 | LT | 08.04.2020 | LV | 08.04.2020 | MC | 08.04.2020 | MK | 08.04.2020 | MT | 08.04.2020 | NL | 08.04.2020 | PL | 08.04.2020 | RO | 08.04.2020 | SE | 08.04.2020 | SI | 08.04.2020 | SK | 08.04.2020 | SM | 08.04.2020 | TR | 08.04.2020 | BG | 08.07.2020 | NO | 08.07.2020 | GR | 09.07.2020 | IS | 08.08.2020 | PT | 17.08.2020 | IE | 21.12.2020 | LU | 21.12.2020 | BE | 31.12.2020 | [2022/33] |
Former [2022/32] | HU | 21.12.2009 | |
AT | 08.04.2020 | ||
CY | 08.04.2020 | ||
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
MC | 08.04.2020 | ||
MK | 08.04.2020 | ||
MT | 08.04.2020 | ||
NL | 08.04.2020 | ||
PL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SI | 08.04.2020 | ||
SK | 08.04.2020 | ||
SM | 08.04.2020 | ||
TR | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
IE | 21.12.2020 | ||
LU | 21.12.2020 | ||
Former [2022/27] | HU | 21.12.2009 | |
AT | 08.04.2020 | ||
CY | 08.04.2020 | ||
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
MC | 08.04.2020 | ||
MT | 08.04.2020 | ||
NL | 08.04.2020 | ||
PL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SI | 08.04.2020 | ||
SK | 08.04.2020 | ||
SM | 08.04.2020 | ||
TR | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
IE | 21.12.2020 | ||
LU | 21.12.2020 | ||
Former [2021/47] | AT | 08.04.2020 | |
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
MC | 08.04.2020 | ||
NL | 08.04.2020 | ||
PL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SI | 08.04.2020 | ||
SK | 08.04.2020 | ||
SM | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
IE | 21.12.2020 | ||
LU | 21.12.2020 | ||
Former [2021/46] | AT | 08.04.2020 | |
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
MC | 08.04.2020 | ||
NL | 08.04.2020 | ||
PL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SI | 08.04.2020 | ||
SK | 08.04.2020 | ||
SM | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
IE | 21.12.2020 | ||
Former [2021/40] | AT | 08.04.2020 | |
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
MC | 08.04.2020 | ||
NL | 08.04.2020 | ||
PL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SI | 08.04.2020 | ||
SK | 08.04.2020 | ||
SM | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2021/24] | AT | 08.04.2020 | |
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
NL | 08.04.2020 | ||
PL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SI | 08.04.2020 | ||
SK | 08.04.2020 | ||
SM | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2021/10] | AT | 08.04.2020 | |
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
NL | 08.04.2020 | ||
PL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SK | 08.04.2020 | ||
SM | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2021/09] | AT | 08.04.2020 | |
CZ | 08.04.2020 | ||
DK | 08.04.2020 | ||
EE | 08.04.2020 | ||
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
IT | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
NL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SM | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2021/08] | DK | 08.04.2020 | |
ES | 08.04.2020 | ||
FI | 08.04.2020 | ||
HR | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
NL | 08.04.2020 | ||
RO | 08.04.2020 | ||
SE | 08.04.2020 | ||
SM | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2021/01] | FI | 08.04.2020 | |
HR | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
NL | 08.04.2020 | ||
SE | 08.04.2020 | ||
BG | 08.07.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2020/50] | FI | 08.04.2020 | |
HR | 08.04.2020 | ||
LT | 08.04.2020 | ||
LV | 08.04.2020 | ||
NL | 08.04.2020 | ||
SE | 08.04.2020 | ||
NO | 08.07.2020 | ||
GR | 09.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2020/48] | FI | 08.04.2020 | |
LT | 08.04.2020 | ||
NL | 08.04.2020 | ||
SE | 08.04.2020 | ||
NO | 08.07.2020 | ||
IS | 08.08.2020 | ||
PT | 17.08.2020 | ||
Former [2020/47] | LT | 08.04.2020 | |
NO | 08.07.2020 | ||
IS | 08.08.2020 | ||
Former [2020/46] | IS | 08.08.2020 | Documents cited: | Search | [A]CN1303858 ; | [X]CN1258520 ; | [X]CN1404851 ; | [X]CN1383868 ; | [X]US2004265397 (WANG GANG [CN], et al) [X] 1-5,7 * paragraphs [0001] , [00 2] * * experiment sample 1;; table 4 * * execution examples 1-4 * * claim 1 *; | [XD]US2005042314 (WU RONG-TSUN [TW]) [XD] 1-7 * paragraph [0016] - paragraph [0017] * * figures 3, 4; example 3 * * claims 1, 6 *; | [X] - KIMURA Y ET AL, "EFFECTS OF STILBENE COMPONENTS OF ROOTS OF POLYGONUM SSP. ON LIVER INJURY IN PEROXIDIZED OIL-FED RATS", PLANTA MEDICA, THIEME VERLAG, DE, (19830101), vol. 49, no. 1, ISSN 0032-0943, pages 51 - 54, XP009030003 [X] 1-6 * the whole document * | [A] - ZHANG WEI ET AL, "Treatment with 2,3,4',5-tetrahydroxystilbene-2-O-.beta.-D-glucoside in atherosclerosis in rats", ZHONGGUO YAOKE DAXUE XUEBAO - JOURNAL OF CHINA PHARMACEUTICAL UNIVERSITY, NANJING, CN, (20070101), vol. 38, no. 3, ISSN 1000-5048, pages 261 - 264, XP008119057 [A] 1-7 * abstract * | [A] - JIA XIN ET AL, "Neuroprotective effect of tetrahydroxystilbene glucoside on the rat model of Parkinson 's disease", ZHONGGUO XIN YAO ZAZHI - CHINESE NEW DRUGS JOURNAL, GAI-KAN BIANJIBU, BEIJING, CN, (20080101), vol. 17, no. 9, ISSN 1003-3734, pages 748 - 752, XP008119058 [A] 1-7 * abstract * | [A] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2001, no. 63, Database accession no. 2001-558353, XP002569662 & CN1303858 A 20010718 (NO 2 MILITARY MEDICAL COLLEGE PLA) [A] 1-7 * abstract * | [AD] - WANG ET AL, "Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-gluco side, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER BV, NL, (20071025), vol. 578, no. 2-3, ISSN 0014-2999, pages 339 - 348, XP022405039 [AD] 1-7 * abstract * * page 340, column l, paragraph 2 * DOI: http://dx.doi.org/10.1016/j.ejphar.2007.09.013 | [A] - KIMURA Y ET AL, "EFFECTS OF NATURALLY OCCURRING STILBENE GLUCOSIDES FROM MEDICINAL PLANTS AND WINE, ON TUNOUR GROWTH AND LUNG METASTASIS IN LEWIS LUNG CARCINOMA-BEARING MICE", JOURNAL OF PHARMACY AND PHARMACOLOGY, ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN, GB, (20001001), vol. 10, no. 52, ISSN 0022-3573, pages 1287 - 1295, XP001069866 [A] 1-7 * abstract * DOI: http://dx.doi.org/10.1211/0022357001777270 | [T] - THERESE BÖHM ET AL, "Food-derived peroxidized fatty acids may trigger hepatic inflammation: A novel hypothesis to explain steatohepatitis", JOURNAL OF HEPATOLOGY, (20130901), vol. 59, no. 3, doi:10.1016/j.jhep.2013.06.002, ISSN 0168-8278, pages 563 - 570, XP055177233 [T] 1-6 * abstract * * page 563, column r, paragraph 2 - page 564, column l, paragraph 2 * * page 566, column r, paragraph l - page 567, column r, paragraph 2 * DOI: http://dx.doi.org/10.1016/j.jhep.2013.04.025 | [X] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2000, no. 52, Database accession no. 2000-558878, XP002741556 & CN1258520 A 20000705 (JIANG D) [X] 1-7 * abstract * | [X] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2003, no. 50, Database accession no. 2003-524106, XP002741557 & CN1404851 A 20030326 (LU W) [X] 1-5,7 * abstract * | [X] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2003, no. 26, Database accession no. 2003-258359, XP002741558 & CN1383868 A 20021211 (ZHANG Y) [X] 1-5,7 * abstract * | [I] - ANDRATSCHKE N ET AL, "Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction", INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, USA, vol. 64, no. 5, doi:10.1016/J.IJROBP.2005.11.042, ISSN 0360-3016, (20060401), pages 1513 - 1518, (20060401), XP024897844 [I] 1-5,7 * abstract * * page 1516, column l, paragraph 1; figure 3; tables 1, 2 * DOI: http://dx.doi.org/10.1016/j.ijrobp.2005.11.042 | [I] - ARCASOY MURAT O, "The non-haematopoietic biological effects of erythropoietin", BRITISH JOURNAL OF HAEMATOLOGY, BLACKWELL PUBLISHING LTD, (20080401), vol. 141, no. 1, ISSN 1365-2141, pages 14 - 31, XP009154897 [I] 1-5,7 * page 20, column l, paragraph l - column r, paragraph 1 * | [A] - TAO YI ET AL, "Identification and determination of the major constituents in traditional Chinese medicinal plantPolygonum multiflorum thunb by HPLC coupled with PAD and ESI/MS", PHYTOCHEMICAL ANALYSIS, (20070501), vol. 18, no. 3, doi:10.1002/pca.963, ISSN 0958-0344, pages 181 - 187, XP055198802 [A] 1-7 * the whole document * DOI: http://dx.doi.org/10.1002/pca.963 | by applicant | US2005042314 | - ARCASOY MO., BR J HAEMATOL., (2008), vol. 141, pages 14 - 31 | - BUNN HF., BLOOD, (2007), vol. 109, pages 868 - 873 | - CORAZZA F. ET AL., PEDIATR RES., (2004), vol. 55, pages 152 - 158 | - DE KANTER R., TOXICOL IN VITRO, (1999), vol. 13, pages 737 - 744 | - DO AMARAL CL. ET AL., ARCH TOXICOL., (2008), vol. 82, pages 363 - 730 | - ECKARDT KU; KURTZ A., EUR J CLIN INVEST., (1992), vol. 89, pages 753 - 760 | - ECKARDT KU; KURTZ A., EUR J CLIN INVEST., (2005), vol. 35, no. 3, pages 13 - 19 | - FISHER JW., EXP BIOL MED (MAYWOOD)., (2003), vol. 228, pages 1 - 14 | - FUNAKOSHI H; NAKAMURA T., CLIN CHIM ACTA., (2003), vol. 327, pages 1 - 23 | - GUAN S. ET AL., PHYTOTHER RES., (2008), vol. 22, pages 660 - 663 | - HODGES VM., CRIT REV ONCOL HEMATOL., (2007), vol. 64, pages 139 - 158 | - IDO A., J GASTROENTEROL., (2005), vol. 40, pages 925 - 931 | - IGUCHI T., STEM CELLS, (1999), vol. 17, pages 82 - 91 | - ISOBE M. ET AL., TRENDS CARDIOVASC MED., (2006), vol. 16, pages 188 - 193 | - ITO W. ET AL., INT ARCH ALLERGY IMMUNOL., (2008), vol. 146, no. 1, pages 82 - 87 | - JIN M. ET AL., EXP BIOL MED (MAYWOOD, (2003), vol. 228, pages 759 - 766 | - KAIHO S; MIZUNO K., ANAL BIOCHEM., (1985), vol. 149, pages 117 - 120 | - KIMURA Y. ET AL., PLANTA MED., (1983), vol. 49, pages 51 - 54 | - KREAMER BL. ET AL., IN VITRO CELL DEV BIOL., (1986), vol. 22, pages 201 - 211 | - LEVEY AS. ET AL., KIDNEY LNT., (2005), vol. 67, pages 2089 - 3100 | - LIU QL. ET AL., J ASIAN NAT PROD RES., (2007), vol. 9, pages 689 - 697 | - LIU Y., AM J PHYSIOL RENAL PHYSIOL., (2004), vol. 287, pages F7 - 16 | - MATSUMOTO K; NAKAMURA T., KIDNEY INT., (2001), vol. 59, pages 2023 - 2038 | - MIZUNO S; NAKAMURA T., REGEN MED., (2007), vol. 2, pages 161 - 170 | - MORITZ KM. ET AL., AM J PHYSIOL., (1997), vol. 273, pages R1829 - 1844 | - OBATOMI DK ET AL., TOXICOL IN VITRO, (1998), vol. 12, pages 725 - 737 | - ORALLO F., CURR MED CHEM., (2008), vol. 15, pages 1887 - 1898 | - PARRISH AR. ET AL., LIFE SCI., (1995), vol. 57, pages 1887 - 1901 | - PASCHOS N., INT J BIOL SCI., (2008), vol. 4, pages 161 - 168 | - ROSENTHAL A. ET AL., EXP HEMATOL., (1987), vol. 13, pages 174 - 184 | - SEPODES B. ET AL., TRANSPL INT., (2006), vol. 19, pages 919 - 926 | - SHANKAR S. ET AL., FRONT BIOSCI., (2007), vol. 12, pages 4839 - 4854 | - SHARMA S. ET AL., PHARMACOLOGY, (2006), vol. 76, pages 69 - 75 | - TAKEO ET AL., YAKUGAKU ZASSHI, (2007), vol. 127, pages 1813 - 1823 | - WANG R. ET AL., NEUROSCIENCE, (2007), vol. 149, pages 739 - 746 | - WANG X. ET AL., EUR J PHARMACOL., (2008), vol. 578, pages 339 - 348 | - WEISS G; GOODNOUGH LT, N ENGL J MED., (2005), vol. 352, pages 1011 - 1023 | - WISH JB; COYNE DW., MAYO CLIN PROC., (2007), vol. 82, pages 1371 - 1380 | - WORTHINGTON RE., EXP HEMATOL., (1987), vol. 15, pages 85 - 92 | - ZARZECKI M. ET AL., POL ARCH MED WEWN., (2004), vol. 112, pages 1211 - 1219 | - ZHANG YZ ET AL., J ASIAN NAT PROD RES., (2007), vol. 9, pages 355 - 363 |